NCT00116116: DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy |
|
|
| Completed | 4 | 70 | US | efavirenz, stavudine extended release, lamivudine | Bristol-Myers Squibb | HIV Infections, AIDS | 06/05 | 06/05 | | |
NCT00055120: When to Start Anti-HIV Drugs in Patients With Opportunistic Infections |
|
|
| Completed | 4 | 283 | US, RoW | Emtricitabine/tenofovir disoproxil fumarate, Lopinavir/ritonavir, Stavudine | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections, AIDS-Related Opportunistic Infections | 09/06 | 08/07 | | |
NCT00342355: Antiretroviral Therapy for Advanced HIV Disease in South Africa |
|
|
| Completed | 4 | 1771 | RoW | Zidovudine, AZT, Stavudine, D4T, Didanosine, DDI, Lamivudine, 3TC, Efavirenz, EFV, Lopinavir/Ritonavir, Kaletra | National Institutes of Health Clinical Center (CC) | HIV | 03/08 | 08/08 | | |
